Home > Sub Committee > Medical Affairs Committee
Medical Affairs Committee
Medical Affairs Committee
Compliance has been increasingly an important issue in pharmaceutical industry, and clear distinction should be made between medical/scientific activities and promotional activities.
Our Medical Affairs Committee is dedicated to contribute improvement of current status by promoting discussions of the issues such as implementation of investigator initiated studies and post-marketing clinical trials in order to develop scientific evidence in Japan, and activation of scientific exchanges among industry, academic researchers and opinion leaders based on compliance.
